Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02760641 · ClinicalTrials.gov registry record · NA

Egg Diet to Improve Metabolic Health and Function

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT02760641: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT02760641 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02760641, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of change in diet quality (carbohydrate restriction versus fat restriction) on body composition, fat distribution, cardiometabolic risk factors, physical function, and quality of life in aging adults with obesity.

Interventions

  • OTHER Egg-based diet (EBD)
  • OTHER Carbohydrate-based diet (CBD)

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2015-01
Est. Completion 2017-07
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02760641 record still lists

NCT02760641 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Egg-based diet (EBD) is the first listed.

NCT02760641 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02760641 about?

NCT02760641 is a clinical study titled "Egg Diet to Improve Metabolic Health and Function". The purpose of this study is to determine the effects of change in diet quality (carbohydrate restriction versus fat restriction) on body composition, fat distribution, cardiometabolic risk factors, physical function, and quality of life in aging adults with obesity.

What is the current status of trial NCT02760641?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-01. Estimated completion is 2017-07.

What interventions are being tested in trial NCT02760641?

The interventions under investigation include: Egg-based diet (EBD) (OTHER), Carbohydrate-based diet (CBD) (OTHER).

Who is sponsoring clinical trial NCT02760641?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02760641's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02760641, the US trial registry maintained by the National Library of Medicine. NCT02760641 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.